ghk-cu copper coordination geometry square-pyramidal Mixed ligand Cu(II) complexes: Square pyramidal vs trigonal bipyramidal with the pyrrole-based dipodal ligand having hydrogen bond acceptors A new square pyramidal copper(II) – Figure 1 from GHK –

I am very happy with my results

Cagrilintide as a stand-alone drug has been studied through Phase 2, [1] but most of the headline cagrilintide numbers people cite actually come from CagriSema the fixed-dose combination of cagrilintide 2.4 mg with semaglutide 2.4 mg which advanced into the Phase 3 REDEFINE program

Selinexor inhibits XPO1 and has been approved for the treatment of patients with relapsed/refractory multiple myeloma after one to three prior lines of therapy in combination with bortezomib or pomalidomide with dexamethasone, or after 3 prior lines with dexamethasone alone

One of the first supplements suggested for hair loss